NCT01633008

Acceptance and Commitment Therapy for Adolescents and Young Adults With Neurofibromatosis and Chronic Pain

Completed EARLY_PHASE1 Last updated 30 September 2019

What this trial tests

EARLY_PHASE1 trial testing ACT Workshop in Neurofibromatosis in 28 participants. Completed in 10 January 2017.

Timeline

15 June 2012

Primary endpoint
1 May 2014

10 January 2017

Quick facts

Lead sponsor	National Cancer Institute (NCI)
Phase	EARLY_PHASE1
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	28
Start date	15 June 2012
Primary completion	1 May 2014
Estimated completion	10 January 2017
Sites	1 location across United States

Drugs / interventions tested

• ACT Workshop

Conditions studied

• Neurofibromatosis — all drugs for Neurofibromatosis →

Sponsor

National Cancer Institute (NCI)

Who can join

Adults 12 to 99, any sex, with Neurofibromatosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background:

* Neurofibromatosis type 1 (NF1) is a genetic disorder that can cause frequent and significant pain. This pain can have a severe impact on a person s quality of life.
* Acceptance and Commitment Therapy (ACT) is a new type of therapy that may help people manage pain. It teaches behavioral techniques that can be used to change how people react to pain. ACT may help people with NF1 cope better with the pain associated with the disorder. Researchers want to test ACT techniques to see if they can improve coping in people with NF1 pain.

Objectives:

\- To see if ACT can help treat chronic pain in adolescents and young adults who have NF1.

Eligibility:

\- Adolescents and young adults between 12 and 21 years of age who have chronic pain associated with NF1.

Design:

* Participants will be screened with a physical exam and medical history. They will also complete a set of questionnaires about their pain levels, quality of life, and medications that they are taking.
* Participants will take part in a training workshop for ACT. It will consist of three 2-hour sessions over 2 consecutive days. The workshop will teach techniques for setting goals that reflect personal values, and changing the focus from pain avoidance to pain management. There will be practice exercises between each session.
* At the end of the workshop, participants will receive a workbook with the exercises to continue to practice at home. Participants will be encouraged to spend at least 20 minutes, three times per week, on these practice exercises.
* There will be a followup phone call to check on pain management after the workshop.
* Three months after the first study visit, participants will complete the study questionnaires again from home. They will provide more information about how they are managing their pain. The questionnaires will be returned by mail in an envelope provided by the study team.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Left to themselves: Time to target chronic pain in childhood rare diseases.
   Sieberg CB, Lebel A, Silliman E, Holmes S, et al · · 2021 · cited 5× · PMID 33774086 · DOI 10.1016/j.neubiorev.2021.03.008